Polypill Shows LDL Lowering Advantage in High risk Primary Prevention Patients - Video
|
Overview
Cardiovascular polypills are important as a fixed-dose combination of medications with proven benefits for the prevention of cardiovascular disease by combining different drug classes in a single pill to simultaneously target more than one risk factor.
Whether the treatment with the CNIC-polypill was at least non-inferior to usual care in terms of low-density lipoprotein cholesterol (LDL-c) and systolic BP (SBP) values in subjects at high or very high risk without a previous cardiovascular event. The switch from conventional treatment to the CNIC-polypill approach in patients at high Cardiovascular risk without a previous event was safe and appears a reasonable strategy to control risk factors and prevent cardiovascular diseases.
Speakers
Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751